RecallRadar
ModerateReported May 20, 2026 (6 weeks ago)

Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tab…

Recalled by Ascend Laboratories, LLC

Product image for Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.
Product image via DailyMed (National Library of Medicine). It may show general packaging and not the exact recalled lot — always confirm using the codes below.

Class II — moderate

Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Ascend Laboratories, LLC has recalled Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tab…, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on May 20, 2026 and was initiated on April 27, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tab…, with approximately 17,304 100-count bottles affected. The company behind the recall is Ascend Laboratories, LLC, based in Bedminster, NJ. The FDA describes the product as: “Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.”

Why was Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tab… recalled?

According to the FDA, the stated reason for the recall is: “Failed Dissolution Specifications.” In plain terms, this recall relates to a potency or effectiveness issue.

This recall means the medicine may be stronger or weaker than its label says, or may not release its ingredient the way it should. That matters because too little medicine may not treat the condition, and too much can cause side effects. Anyone taking an affected product is generally advised to consult their pharmacist or doctor about a replacement.

What should you do?

If you think you may have bought Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tab…, compare it against the product description and identifying codes (Lot # 25140859; Exp. Date: Jan 2027) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Ascend Laboratories, LLC or your local health authority.

About this recall

This recall was distributed in NJ. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.

Full recall details

Status
Ongoing
Date reported
May 20, 2026
Recall started
April 27, 2026
Distributed in
NJ
What was recalled
Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.
Why it was recalled (as stated by the FDA)
Failed Dissolution Specifications
How to identify the affected product
Lot # 25140859; Exp. Date: Jan 2027
Amount recalled
17,304 100-count bottles

What you can do

Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.

Quick answers

Why was Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tab… recalled?+

According to the FDA: Failed Dissolution Specifications

How serious is this recall?+

Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

What should I do if I have Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tab…?+

Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.

Share this recall:PostShareEmail
View the official FDA record

Opens the U.S. Food and Drug Administration (FDA) data for this recall.

Recall number: D-0547-2026. Information last synced from the FDA on July 6, 2026.

Related recalls